Diabetes drug may fight anemia in kidney patients
NCT ID NCT07334145
Summary
This study will test whether SGLT2 inhibitor drugs, typically used for diabetes, can help improve anemia in people with chronic kidney disease. Researchers will measure changes in hemoglobin levels in 60 adult participants with stable anemia. The goal is to see if these medications offer a new way to manage this common and challenging complication of kidney disease.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ANEMIA IN CKD PATIENTS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Sohag University Hospital
Sohag, Sohag University, Egypt
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.